arrow
G

Giulia Arrivi

“sapienza” university of rome
H指数:10
被引数:314

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinicomics for Predicting HER2 Expression in Metastatic Colorectal Cancer: A Multicenter Machine Learning Analysis on Real-World Data

Clinicomics在预测转移性结直肠癌HER2表达中的应用:一项基于真实世界数据的 multicenter 机器学习分析

2025-12-010
PRE
Prognostic value, clinical relevance, and methodological gaps of tumor burden in neuroendocrine tumors (NETs): a systematic review of phase III randomized trials of medical therapies

预后价值、临床相关性及神经内分泌肿瘤(NETs)肿瘤负荷的方法学缺陷:医疗疗法III期随机试验的系统综述

2025-11-280
OAAI
Radiomic and Clinical–Pathological Factors Predictive of Postoperative Recurrence in Lung Neuroendocrine Tumors: A Pilot Study

放射组学和临床–病理学因素预测肺神经内分泌肿瘤术后复发的初步研究

2025-11-280
OAAI
Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study

真实世界证据:regorafenib剂量递增与固定剂量在难治性转移性结直肠癌中的比较:ReTrITA研究的结果

2025-10-140
OAAI
Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis
2024-04-131
OAAI
Predictive and prognostic impact of primary tumor location on sequential treatment with regorafenib and trifluridine/tipiracil at third line and beyond in metastatic colorectal cancer: A real-world multicenter retrospective analysis
2023-10-011
PRE
The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives
2023-06-014
PRE
Influence of age on disease control rate of patients treated with regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A multicenter retrospective real-world study
2023-06-010
OA